APA

Zhao M., Howard E. W., Parris A. B., Guo Z., Zhao Q., Ma Z., Xing Y., Liu B., Edgerton S. M., Thor A. D. & Yang X. (20170925). Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells. : Oncotarget.

Chicago

Zhao Ming, Howard Erin W, Parris Amanda B, Guo Zhiying, Zhao Qingxia, Ma Zhikun, Xing Ying, Liu Bolin, Edgerton Susan M, Thor Ann D and Yang Xiaohe. 20170925. Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells. : Oncotarget.

Harvard

Zhao M., Howard E. W., Parris A. B., Guo Z., Zhao Q., Ma Z., Xing Y., Liu B., Edgerton S. M., Thor A. D. and Yang X. (20170925). Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells. : Oncotarget.

MLA

Zhao Ming, Howard Erin W, Parris Amanda B, Guo Zhiying, Zhao Qingxia, Ma Zhikun, Xing Ying, Liu Bolin, Edgerton Susan M, Thor Ann D and Yang Xiaohe. Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells. : Oncotarget. 20170925.